logging in or signing up class lecture MYASTHENIA GRAVIS pradeep1842000 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 1867 Category: Education License: All Rights Reserved Like it (4) Dislike it (0) Added: August 21, 2010 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript MYASTHENIA GRAVIS : MYASTHENIA GRAVIS Myasthenia gravis (MG) is a rare autoimmune disease. It is a disorder of neuromuscular function thought to be due to the presence of antibodies to acetylcholine receptors at the neuromuscular junction SYMPTOMS : SYMPTOMS Drooping of the eyelids Double vision Difficulty smiling, speaking, swallowing Difficulty raising the arms Difficulty walking Difficulty breathing if chest muscle are affected Pathogenesis : Pathogenesis 1) In MG, underlying defect is a decrease in the number of available acetylcholine receptors (AChR) at postsynaptic muscle membrane 2) Postsynaptic folds are flattened or “simplified”, causing less efficient neuromuscular transmission Diagnosis : Diagnosis History and Physical “Tensilon Test” Repetitive Nerve Stimulation AChR antibody testing Single Fiber EMG History and Physical : History and Physical Diplopia, ptosis Fatigability Reduced strength on exam Reduced vital capacity Tensilon Test : Tensilon Test Edrophonium is an AChE inhibitor Rapid onset (30s) and short duration of action (about 5 minutes) Focus on a weak muscle group and evaluate. Initial dose of 2mg given I.V. If no change, give additional 8mg I.V. AChR Antibodies : AChR Antibodies Measured level does NOT correspond well with severity of disease In an individual patient, however, treatment-induced fall in the antibody level often correlates with clinical improvement Treatment : Treatment AChE inhibitors Pyridostigmine (Mestinon) Immunosuppression Rapid immunomodulating treatments Plasma exchange Thymectomy AChE inhibitors : AChE inhibitors Neostigmine Treatment start with this drug. 15 mg orally, 6 hourly. Dose is adjusted according to the response. Alternative drug Pyridostigmine (Mestinon) Effect starts in 15-30 minutes, lasts 3-4 hours Titrate dosage to symptoms Cholinergic symptoms can limit use Plasmapheresis : Plasmapheresis Plasmapheresis Pathogenic antibodies removed Usually a course of 5 exchanges over a 2 week period Useful for temporary relief of symptoms Immunosuppression : Immunosuppression Glucocorticoids inhibit 1) production of NR-antibodies 2) increase synthesis of NRs. Immunosuppressant (Azathioprine, cyclosporin) Inhibit NR-antibodies synthesis by affecting T-cells Glucocorticoids and cyclosporin generally produce improvement within 1-3 months Azathioprine and mycophenolate take up to a year to show effect Thymectomy : Thymectomy Thymus has modified musle cells having NRs which is a source of antigen for the production of anti-NR antibodies in MG. In the absence of tumor, 85% of patients have improvement after thymectomy Improvement takes months to years You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
class lecture MYASTHENIA GRAVIS pradeep1842000 Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT lite Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 1867 Category: Education License: All Rights Reserved Like it (4) Dislike it (0) Added: August 21, 2010 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript MYASTHENIA GRAVIS : MYASTHENIA GRAVIS Myasthenia gravis (MG) is a rare autoimmune disease. It is a disorder of neuromuscular function thought to be due to the presence of antibodies to acetylcholine receptors at the neuromuscular junction SYMPTOMS : SYMPTOMS Drooping of the eyelids Double vision Difficulty smiling, speaking, swallowing Difficulty raising the arms Difficulty walking Difficulty breathing if chest muscle are affected Pathogenesis : Pathogenesis 1) In MG, underlying defect is a decrease in the number of available acetylcholine receptors (AChR) at postsynaptic muscle membrane 2) Postsynaptic folds are flattened or “simplified”, causing less efficient neuromuscular transmission Diagnosis : Diagnosis History and Physical “Tensilon Test” Repetitive Nerve Stimulation AChR antibody testing Single Fiber EMG History and Physical : History and Physical Diplopia, ptosis Fatigability Reduced strength on exam Reduced vital capacity Tensilon Test : Tensilon Test Edrophonium is an AChE inhibitor Rapid onset (30s) and short duration of action (about 5 minutes) Focus on a weak muscle group and evaluate. Initial dose of 2mg given I.V. If no change, give additional 8mg I.V. AChR Antibodies : AChR Antibodies Measured level does NOT correspond well with severity of disease In an individual patient, however, treatment-induced fall in the antibody level often correlates with clinical improvement Treatment : Treatment AChE inhibitors Pyridostigmine (Mestinon) Immunosuppression Rapid immunomodulating treatments Plasma exchange Thymectomy AChE inhibitors : AChE inhibitors Neostigmine Treatment start with this drug. 15 mg orally, 6 hourly. Dose is adjusted according to the response. Alternative drug Pyridostigmine (Mestinon) Effect starts in 15-30 minutes, lasts 3-4 hours Titrate dosage to symptoms Cholinergic symptoms can limit use Plasmapheresis : Plasmapheresis Plasmapheresis Pathogenic antibodies removed Usually a course of 5 exchanges over a 2 week period Useful for temporary relief of symptoms Immunosuppression : Immunosuppression Glucocorticoids inhibit 1) production of NR-antibodies 2) increase synthesis of NRs. Immunosuppressant (Azathioprine, cyclosporin) Inhibit NR-antibodies synthesis by affecting T-cells Glucocorticoids and cyclosporin generally produce improvement within 1-3 months Azathioprine and mycophenolate take up to a year to show effect Thymectomy : Thymectomy Thymus has modified musle cells having NRs which is a source of antigen for the production of anti-NR antibodies in MG. In the absence of tumor, 85% of patients have improvement after thymectomy Improvement takes months to years